Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet.

Focal cortical dysplasia - review. Pol J Radiol (2012) 0.98

Increased tryptophan transport in epileptogenic dysembryoplastic neuroepithelial tumors. J Neurooncol (2011) 0.89

Usefulness of FDG, MET and FLT-PET studies for the management of human gliomas. J Biomed Biotechnol (2012) 0.83

PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns. Eur J Nucl Med Mol Imaging (2011) 0.82

Epileptogenic brain lesions in children: the added-value of combined diffusion imaging and proton MR spectroscopy to the presurgical differential diagnosis. Childs Nerv Syst (2011) 0.77

Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) Combined with Positron Emission Tomography-Computed Tomography (PET-CT) and Video-Electroencephalography (VEEG) Have Excellent Diagnostic Value in Preoperative Localization of Epileptic Foci in Children with Epilepsy. Med Sci Monit (2017) 0.75

PET and SPECT studies in children with hemispheric low-grade gliomas. Childs Nerv Syst (2016) 0.75

Imaging Spectrum and Pitfalls of (11)C-Methionine Positron Emission Tomography in a Series of Patients with Intracranial Lesions. Korean J Radiol (2016) 0.75

Discrepancy between radiological and histological findings in ganglioglioma of the optic chasm: Case report. Surg Neurol Int (2017) 0.75

Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature (2012) 4.13

Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging (2008) 2.55

Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. Lancet Oncol (2012) 2.34

Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya disease. Neurosurgery (2006) 2.29

Performance measurement of the microPET focus 120 scanner. J Nucl Med (2007) 2.10

Posterior cerebral artery involvement in moyamoya disease: initial infarction and angle between PCA and basilar artery. Childs Nerv Syst (2013) 2.06

Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics (2002) 1.99

Cytogenetic and molecular genetic study on granular cell glioblastoma: a case report. Hum Pathol (2012) 1.95

Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol (2011) 1.88

Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging. Radiology (2014) 1.87

Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B cell lymphoma. Cancer (2012) 1.84

The enigma of bifocal germ cell tumors in the suprasellar and pineal regions: synchronous lesions or metastasis? J Neurosurg Pediatr (2012) 1.75

Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med (2006) 1.72

Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med (2005) 1.59

Shunt dependency in shunted arachnoid cyst: a reason to avoid shunting. Pediatr Neurosurg (2002) 1.57

Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56

PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med (2003) 1.52

Venous-predominant parenchymal arteriovenous malformation: a rare subtype with a venous drainage pattern mimicking developmental venous anomaly. J Neurosurg (2008) 1.52

A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med (2009) 1.51

Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2014) 1.48

Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res (2006) 1.44

Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation. J Thorac Oncol (2015) 1.44

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43

Preuntethering and postuntethering courses of syringomyelia associated with tethered spinal cord. Neurosurgery (2012) 1.43

Multiple pulmonary atypical carcinoids presenting with long-standing Cushing syndrome masked by pulmonary tuberculosis. Pathol Int (2009) 1.42

Persistent brain network homology from the perspective of dendrogram. IEEE Trans Med Imaging (2012) 1.41

Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells (2009) 1.40

Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr (2010) 1.39

Let-7 microRNA inhibits the proliferation of human glioblastoma cells. J Neurooncol (2010) 1.39

Ictal SPECT using an attachable automated injector: clinical usefulness in the prediction of ictal onset zone. Acta Radiol (2009) 1.38

Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res (2009) 1.38

Terminal myelocystocele: surgical observations and theory of embryogenesis. Neurosurgery (2012) 1.37

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med (2008) 1.32

Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2008) 1.30

Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med (2009) 1.30

Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation. J Nucl Med (2008) 1.29

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity. Acta Neuropathol (2014) 1.28

IDH1 mutation of gliomas with long-term survival analysis. Oncol Rep (2012) 1.25

Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small (2011) 1.23

Tractography-guided statistics (TGIS) in diffusion tensor imaging for the detection of gender difference of fiber integrity in the midsagittal and parasagittal corpora callosa. Neuroimage (2007) 1.22

Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol (2010) 1.22

Sparse brain network recovery under compressed sensing. IEEE Trans Med Imaging (2011) 1.19

Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study. Am J Psychiatry (2003) 1.19

Bioimaging of the unbalanced expression of microRNA9 and microRNA9* during the neuronal differentiation of P19 cells. FEBS J (2008) 1.17

In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma. J Nucl Med (2008) 1.17

Tumoral calcinosis of the hand: three unusual cases with painful swelling of small joints. Arch Pathol Lab Med (2006) 1.16

Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging (2002) 1.16

Surgical completeness of bilateral axillo-breast approach robotic thyroidectomy: comparison with conventional open thyroidectomy after propensity score matching. Surgery (2011) 1.15

Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol (2007) 1.15

Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology (2005) 1.14

Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. Cancer Res (2010) 1.14

Papillary tumor of pineal region presenting with leptomeningeal seeding. Neuropathology (2010) 1.12

Cortical activity at rest predicts cochlear implantation outcome. Cereb Cortex (2006) 1.12

Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg (2005) 1.12

Speech perception after cochlear implantation over a 4-year time period. Acta Otolaryngol (2003) 1.11

Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res (2003) 1.11

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation (2006) 1.11

Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke (2005) 1.10

HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine (2011) 1.09

Preoperative differences of cerebral metabolism relate to the outcome of cochlear implants in congenitally deaf children. Hear Res (2005) 1.09

Pediatric brain tumors: statistics of SNUH, Korea (1959-2000). Childs Nerv Syst (2002) 1.09

In reply. Neurosurgery (2013) 1.08

Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med (2003) 1.08